All Stories

  1. Artificial RNA editing with ADAR for gene therapy
  2. Comparative Activity of Adenosine Deaminase Acting on RNA (ADARs) Isoforms for Correction of Genetic Code in Gene Therapy
  3. Chemical RNA Editing for Genetic Restoration: The Relationship between the Structure and Deamination Efficiency of Carboxyvinyldeoxyuridine Oligodeoxynucleotides
  4. Changing Blue Fluorescent Protein to Green Fluorescent Protein Using Chemical RNA Editing as a Novel Strategy in Genetic Restoration
  5. Alternative splicing regulation of APP exon 7 by RBFox proteins
  6. A View of Pre-mRNA Splicing from RNase R Resistant RNAs
  7. Computational extraction of a neural molecular network through alternative splicing
  8. Nested introns in an intron: Evidence of multi-step splicing in a large intron of the human dystrophin pre-mRNA
  9. Alternative splicing produces structural and functional changes in CUGBP2
  10. Functional Gene Expression Analysis of Tissue-Specific Isoforms of Mef2c
  11. Possibility of genetic restoration for a disease treatment
  12. Comprehensive Analysis of Alternative Splicing and Functionality in Neuronal Differentiation of P19 Cells
  13. Retinoic acid treatment and cell aggregation independently regulate alternative splicing in P19 cells during neural differentiation
  14. Alternative splicing ofMef2cpromoted by Fox-1 during neural differentiation in P19 cells
  15. Multi-wall carbon nanotubes (MWCNTs)-doped polypyrrole DNA biosensor for label-free detection of genetically modified organisms by QCM and EIS
  16. Expression analysis of Fgf8a & Fgf8b in early stage of P19 cells during neural differentiation
  17. An effective method for the in situ synthesis of DNA–CPG conjugates using chemical ligation technology as tools for SNP analysis
  18. A new hydrophobic linker effective for the in situ synthesis of DNA–CPG conjugates as tools for SNP analysis
  19. JAIST International Symposium on Nanotechnology 2006 (NT2006)
  20. Upregulations ofGata4 and oxytocin receptor are important in cardiomyocyte differentiation processes of P19CL6 cells
  21. Hesr1knockout mice exhibit behavioral alterations through the dopaminergic nervous system
  22. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-α2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
  23. NSSRs/TASRs/SRp38s function as splicing modulators via binding to pre-mRNAs
  24. Prediction of tertiary structure of NSSRs’ RNA recognition motif and the RNA binding activity
  25. Probe-on-carriers for oligonucleotide microarrays (DNA chips)
  26. Increased expression level of the splicing variant of SIP1 in motor neuron diseases
  27. CDNA microarray analysis of gene expression in fibroblasts of patients with x-linked Emery-Dreifuss muscular dystrophy
  28. Nuclear accumulation of expandedPABP2 gene product in oculopharyngeal muscular dystrophy
  29. Changes in pre-mRNA splicing factors during neural differentiation in P19 embryonal carcinoma cells
  30. Apoptosis in favourable neuroblastomas is not dependent on Fas (CD95/APO‐1) expression but on activated caspase 3 (CPP32)
  31. Apoptosis in favourable neuroblastomas is not dependent on Fas (CD95/APO-1) expression but on activated caspase 3 (CPP32)
  32. Cloning and characterization of two neural-salient serine/arginine-rich (NSSR) proteins involved in the regulation of alternative splicing in neurones
  33. RA70 Is a Src Kinase-Associated Protein Expressed Ubiquitously
  34. Presence of emerinopathy in cases of rigid spine syndrome
  35. Mutations in the integrin α7 gene cause congenital myopathy
  36. Wortmannin enhances activation of CPP32 (Caspase-3) induced by TNF or anti-Fas
  37. Clinical and genetic analyses of Emery-Dreifuss muscular dystrophy and rigid spine syndrome
  38. Involvement ofSonic hedgehogin the Cell Growth of LK-2 Cells, Human Lung Squamous Carcinoma Cells
  39. Wortmannin Enhances CPP32-like Activity during Neuronal Differentiation of P19 Embryonal Carcinoma Cells Induced by Retinoic Acid
  40. Emerin deficiency at the nuclear membrane in patients with Emery-Dreif uss muscular dystrophy
  41. WS-14-1 Deficiency of laminin α2 chain in muscle and nerve tissues and muscular dystrophy
  42. Deficiency of laminin ?2-Chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy
  43. Regulation of alternative splicing in the amyloid precursor protein (APP) mRNA during neuronal and glial differentiation of P19 embryonal carcinoma cells
  44. Identification of a third ubiquitous calpain species — chicken muscle expresses four distinct calpains
  45. Alternative splicing of β-tropomyosin pre-mRNA: multiple cis-elements can contribute to the use of the 5′- and 3′-splice sites of the nonmuscle/smooth muscle exon 6
  46. Laminin in Animal Models for Muscular Dystrophy Defect of Laminin M in Skeletal and Cardiac Muscles and Peripheral Nerve of the Homozygous Dystrophic dy/dy Mice.
  47. Changes of lysosomal proteinase activities and their expression in rat cultured keratinocytes during differentiation
  48. 26S multicatalytic proteinase complexes decrease during the differentiation of murine erythroleukemia cells
  49. Aminopeptidase A in human placenta and pregnant serum
  50. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy
  51. Identification of an elastase-like activity, that decreased during the differentiation of mel cells, as a prolyl endopeptidase
  52. Molecular cloning of cDNAs for two subunits of rat multicatalytic proteinase. Existence of N-terminal conserved and C-terminal diverged sequences among subunits
  53. Calcium is essential for both the membrane binding and lytic activity of pore-forming protein (perforin) from cytotoxic T-lymphocyte
  54. Distribution of Alzheimer's disease amyloid A4-generating enzymes in rat brain tissue
  55. Changes in proteinase activities during the differentiation of murine erythroleukemia cells
  56. Detection of a fast isoform of C-protein with an antiserum directed against the N-terminal portion of dystrophin
  57. Identification of a putative amyloid A4-generating enzyme as a prolyl endopeptidase
  58. Molecular and biochemical properties of the ATP-stimulated multicatalytic proteinase, ingensin, from rat liver
  59. Antiserum against the synthetic polypeptide fragment of dystrophin cross-reacts with Myofibrillar C-protein.
  60. Putative N -terminal splitting enzyme of amyloid A4 peptides is the multicatalytic proteinase, ingensin, which is widely distributed in mammalian cells
  61. Addition of ATP increases the apparent molecular mass of the multicatalytic proteinase, ingensin
  62. RNA degrading activity is tightly associated with the multicatalytic proteinase, ingensin
  63. Mature 98,000-dalton acid ?-glucosidase is deficient in Japanese quails with acid maltase deficiency
  64. Dystrophin digest
  65. Mosaic Expression of Dystrophin in Symptomatic Carriers of Duchenne's Muscular Dystrophy
  66. An ATP-dependent protease and ingensin, the multicatalytic proteinase, in K562 cells
  67. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide
  68. Biosyntheses and processing of lysosomal cysteine proteinases in rat macrophages
  69. The "ATP-dependent protease" in human erythroleukemia (K562) cells is identical to a high-molecular-mass protease, ingensin.
  70. Localization of BLT serine esterase is distinct from that of perforin in cytotoxic T lymphocyte.
  71. Negative immunostaining of Duchenne muscular dystrophy(DMD) and mdx muscle surface membrane with antibody against synthetic peptide fragment predicted from DMD cDNA.
  72. Autodegradation of lysosomal cysteine proteinases
  73. Studies on thiol proteinase inhibitors in rat peripheral blood cells
  74. A Comparative Gene Expression Analysis of Emery-Dreifuss Muscular Dystrophy Using a cDNA Microarray